CLC genomics WB, network plus
Ended Purchase Order Awarded Last action
- Contract number
- W81XWH21P0169
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,056,761
Award facts
- Opportunity
-
- CLC licenses Special Notice · W81XWH21Q0189 · Posted Aug 4, 2021
- Contract value 100% obligated
- $1,056,760.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541512 Computer Systems Design Services
- Set-aside
- No set-aside
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $226,833 | |
| Exercise an Option | $220,226 | |
| Exercise an Option | $213,812 | |
| Exercise an Option | $207,552 | |
| Original award | $188,338 |
About this award
The Defense Health Agency awarded a $1.06 million firm fixed-price purchase order to Qiagen, LLC on September 3, 2021, for licenses and software maintenance related to the CLC Genomics Workbench platform. The contract, which extends through September 27, 2026, consolidates multiple existing software and maintenance agreements into a single arrangement with Qiagen, the sole source provider of the CLC Bio Genomics Factory Platform software used by the Armed Forces DNA Identification Laboratory to analyze and visualize next-generation sequencing data. The procurement was conducted without a set-aside designation on a sole-source basis, with performance taking place at Qiagen's Germantown, Maryland facility. The originating special notice, posted in August 2021, indicated this consolidation was necessary because Qiagen represents the only reasonably available source capable of providing the specialized bioinformatics software and associated support services required to maintain compliance with the Risk Management Framework for the Armed Forces Medical Examiner System and DNA identification operations.
Qiagen, LLC, a Germantown-based subsidiary of Netherlands-headquartered Qiagen N.V., is a manufacturer of molecular diagnostics and bioinformatics solutions with an established track record of providing specialized equipment, reagents, and software to federal agencies including the Department of Defense, National Institutes of Health, and Centers for Disease Control and Prevention. This contract represents part of the company's broader portfolio of federal work supporting critical defense and public health initiatives, leveraging Qiagen's expertise in genomic analysis tools and laboratory instrumentation maintenance to support military forensic and identification capabilities.
Quick answers
Who was awarded contract W81XWH21P0169?
W81XWH21P0169 was awarded to Qiagen, LLC by Defense Health Agency (Department of Defense) on September 3, 2021.
How much is contract W81XWH21P0169 worth?
The government has obligated $1,056,761 on W81XWH21P0169.
Was contract W81XWH21P0169 competed?
The extent of competition for W81XWH21P0169 was not available for competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award